loadpatents
name:-0.02825403213501
name:-0.023040056228638
name:-0.009364128112793
Moingeon; Philippe Patent Filings

Moingeon; Philippe

Patent Applications and Registrations

Patent applications and USPTO patent grants for Moingeon; Philippe.The latest application filed is for "il-10 as a predictive biomarker of responsiveness to house dust mite allergen immunotherapy".

Company Profile
7.24.26
  • Moingeon; Philippe - Antony FR
  • Moingeon; Philippe - Verrieres le Buisson FR
  • Moingeon; Philippe - Verrieres-Ie-Buisson FR
  • Moingeon; Philippe - Pommiers FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
IL-10 as a predictive biomarker of responsiveness to house dust mite allergen immunotherapy
Grant 11,028,441 - Mascarell , et al. June 8, 2
2021-06-08
Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids
Grant 11,027,010 - Moingeon , et al. June 8, 2
2021-06-08
Markers of immune response
Grant 11,015,221 - Mascarell , et al. May 25, 2
2021-05-25
Sialylated fetuin-A as a marker of immunotherapy efficacy
Grant 10,884,002 - Lombardi , et al. January 5, 2
2021-01-05
Compositions for antigen-specific induction of tolerance
Grant 10,610,586 - Moingeon , et al.
2020-04-07
Methods for identifying dendritic cell subsets, for determining if a patient is developing a regulatory or an effector immune response, and for determining response to immunotherapy
Grant 10,190,166 - Moingeon , et al. Ja
2019-01-29
Il-10 As A Predictive Biomarker Of Responsiveness To House Dust Mite Allergen Immunotherapy
App 20190024177 - MASCARELL; Laurent ;   et al.
2019-01-24
Biomarkers of immunotherapy efficacy
Grant 10,101,341 - Bodo , et al. October 16, 2
2018-10-16
Recombinant Der P 2 expressed in Pichia Pastoris as a "natural-like" allergen for immunotherapy and diagnostic purposes
Grant 9,868,770 - Bordas , et al. January 16, 2
2018-01-16
Sialylated Fetuin-a As A Marker Of Immunotherapy Efficacy
App 20170370946 - LOMBARDI; Vincent ;   et al.
2017-12-28
Use of IGG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and incidents via the mucosa
Grant 9,822,185 - Batard , et al. November 21, 2
2017-11-21
Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids
Grant 9,795,644 - Moingeon , et al. October 24, 2
2017-10-24
Markers Of Immune Response
App 20170233816 - MASCARELL; Laurent ;   et al.
2017-08-17
Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids
App 20170224810 - MOINGEON; Philippe ;   et al.
2017-08-10
Composition Of Allergen Extracts Having Reduced Toxicity And Method Of Production Thereof
App 20170157240 - NONY; Emmanuel ;   et al.
2017-06-08
Compositions For Antigen-Specific Induction of Tolerance
App 20170043013 - MOINGEON; Philippe ;   et al.
2017-02-16
Compositions for antigen-specific induction of tolerance
Grant 9,555,102 - Moingeon , et al. January 31, 2
2017-01-31
C1q as a therapeutic agent of allergy and/or asthma
App 20160367631 - MASCARELL; Laurnt ;   et al.
2016-12-22
Mucoadhesive particulate formulation for inducing antigen-specific immune tolerance
Grant 9,480,748 - Saint-Lu , et al. November 1, 2
2016-11-01
Use Of Igg1 Immunoglobulins And/or Ligands Of The Cd32 Receptor For Treating Inflammatory Diseases And Incidents Via The Mucosa
App 20160032018 - Batard; Thierry ;   et al.
2016-02-04
Use of IgG.sub.1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and manifestations via the mucosal route
Grant 9,187,568 - Batard , et al. November 17, 2
2015-11-17
Methods For Identifying Dendritic Cell Subsets, For Determining If A Patient Is Developing A Regulatory Or An Effector Immune Response, And For Determining Response To Immunotherapy
App 20140377761 - Moingeon; Philippe ;   et al.
2014-12-25
Biomarkers Of Immunotherapy Efficacy
App 20140112955 - Bodo; Veronique ;   et al.
2014-04-24
Mucoadhesive Particulate Formulation For Inducing Antigen-specific Immune Tolerance
App 20140079795 - SAINT-LU; Nathalie ;   et al.
2014-03-20
Method for grass species identification
Grant 8,632,993 - Moingeon , et al. January 21, 2
2014-01-21
Immunogenic Polypeptides Encoded by MAGE Minigenes and Uses Thereof
App 20130216563 - Berinstein; Neil ;   et al.
2013-08-22
Immunogenic polypeptides encoded by MAGE minigenes and uses thereof
Grant 8,257,717 - Berinstein , et al. September 4, 2
2012-09-04
Use Of Igg1 Immunoglobulins And/or Ligands Of The Cd32 Receptor For Treating Inflammatory Diseases And Manifestations Via The Mucosal Route
App 20120171198 - Batard; Thierry ;   et al.
2012-07-05
Method for Grass Species Identification
App 20120171710 - Moingeon; Philippe ;   et al.
2012-07-05
Reduction Of In Vitro Genotoxicity Of Pollen Extracts By Removal Of Flavonoids
App 20120148626 - Moingeon; Philippe ;   et al.
2012-06-14
Method of Inducing and/or Enhancing an Immune Response to Tumor Antigens
App 20110319480 - Berinstein; Neil ;   et al.
2011-12-29
Recombinant Der P 2 Expressed in Pichia Pastoris as a "Natural-Like" Allergen for Immunotherapy and Diagnostic Purposes
App 20110293665 - BORDAS; Veronique ;   et al.
2011-12-01
Immunogenic Polypeptides Encoded by MAGE Minigenes and Uses Thereof
App 20110250234 - Berinstein; Neil ;   et al.
2011-10-13
Method of inducing and/or enhancing an immune response to tumor antigens
Grant 8,017,590 - Berinstein , et al. September 13, 2
2011-09-13
Mucoadhesive Particulate Formulation For Inducing Antigen-specific Immune Tolerance
App 20110150987 - Saint-Lu; Nathalie ;   et al.
2011-06-23
Immunogenic polypeptides encoded by MAGE minigenes and uses thereof
Grant 7,851,212 - Berinstein , et al. December 14, 2
2010-12-14
Methods of Inducing and/or Enhancing an Immune Response To Tumor Antigens
App 20100260807 - Berinstein; Neil ;   et al.
2010-10-14
Mite Fusion Proteins
App 20080274059 - MOINGEON; Philippe ;   et al.
2008-11-06
Compositions For Antigen-Specific Induction of Tolerance
App 20080233155 - Moingeon; Philippe ;   et al.
2008-09-25
Immunogenic polypetides encoded by mage minigenes and uses thereof
App 20040033234 - Berinstein, Neil ;   et al.
2004-02-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed